Saturday, April 13, 2013

Jumpvine.com - Website for Sale on Flippa: PPC Advertising ...

Own Your Own Ad Network!

Jumpvine.com - PPC Advertising Network

Jumpvine is a powerful, feature rich, fully customizable PayPerClick advertiser/publisher network. Advertisers can register with the adserver and? post their text/banner/catalog PayPerClick (PPC) ads. Publishers can create ad display units and?use it in their websites to show ads relevant to their page content. You can completely control your revenue from the system by adjusting the minimum click bid value as well as the percentage of click bids you would share with publishers. The system comes with support for load balancing across multiple servers which means you never need to worry about performance bottlenecks. The entire system is template driven which allows you to easily modify the advertiser, publisher pages to your preference. Also the system comes in 14 languages and you can add more.

Manage Publishers

Jumpvine.com?allows you to manage your publishers effectively than ever.?You can review each publisher account before approving the same. The system allows you to to specify the click bid percentage to be shared with publishers. You can get details about his click and profit statistics, fraud statistics and withdrawal history anytime. The robust and improved fraud control measures allows you to monitor,?warn and block suspicious publishers.

Manage Advertisers

Now using?Jumpvine.com you can manage your advertisers in a better way. You can review their ads and if you find their ads? inappropriate for your terms, you may block their accounts. You can check the complete profile of an advertiser which contains information about ads posted by the advertiser, click statistics of the advertiser and payment history. Also you have the option for adding fund to advertiser's bonus/account balance.

Is Jumpvine your future?

Jumpvine.com is a custom designed advertising network similar to that of google adsense and adwords. It is basically your very own advertising network. Jumpvine uses?a very sophisticated advertising platform in the backend,

Just a few years ago starting your own ad network wasn?t easy nor within reach for the regular person and the capital needed was huge!

Jumpvine has everything you need to run your own ad network and start selling traffic.

Why would you want to start your own ad network?

Because there is a lot of money being made in selling media. Any affiliate or business that has a product to sell online needs traffic. Traffic is the lifeblood of any business.

Advertising is one of the few industries that just keeps growing each year. More and more companies spend money on online advertising and there is no limit to how much money you can make.

Jumpvine?is very simple and easy to run even for a beginner,?doesn't require any exerience or maintenance. Jumpvine is perfect for?anyone including webmasters who are looking to?advertise?their brand, develop traffic to their sites and acquire?more customers. With millions of existing websites and new websites?being created every day, you will have no shortage of customers who want?to buy the services offered by Jumpvine.com - The new kid on the block!

Selling traffic is a very scalable business model and very sustainable.

- Full control of your ad network. You can approve, suspend and terminate accounts.

Jumpvine is a great investment for those that own several websites. With skyrocketing cost of advertising on Google and Bing. With the right person at the helm Jumpvine has the potential to give either of them a run for their money and save the owner a ton of money.

What's Included

Jumpvine.com domain and custom designed ad network website.

Why?am I?selling?

At the moment I am involved in non-internet project that will consume most of my time.

?Jumpvine is a beautiful site that?is capable of making?a hansom monthly revenue and growing in value.

Currently the site makes no revenue as it has not been advertised. I was nearing the end of development of the site when?my?non-internet project starting taking off.?

This will be a 10-day auction with the ad network going to the highest bidder once the reserve has been met.?

Happy Bidding!

To express your interest to the seller, or post a public comment, you need to log in or sign up.

Source: https://flippa.com/2886942-ppc-advertising-network-for-sale-own-your-own-ad-network

KTLA Ash Wednesday 2013 ted nugent Pope Resigns westminster dog show Christopher Dorner Manifesto mardi gras

Monday, April 8, 2013

3Gbps LED light bulb WLAN acheived by Fraunhofer Heinrich Hertz Institute

Image

We first noted it back in 2008: the possibility of using LED light bulbs for secure and directional wireless internet access. Well, the Fraunhofer Heinrich Hertz Institute is claiming that speedy data rates of up 3Gbps have proven feasible in its labs. The boost comes from its latest enhancements, allowing the 180Mhz frequency to be used over the usual 30Mhz, which apparently leaves extra room for moving data. If you'll recall, that's a significant leap over the 800Mbps top speed it achieved back in 2011 mixing various light colors. While this IR-like take on wireless internet access gains steam, remember that it's more likely to be used in areas where WiFi radios cause interruptions (hospitals, trade shows like CES, etc.) -- rather than a strip of mini spot lights from IKEA for the casa. (We can dream, can't we?) FHHI plans to show off the new gear at FOE '13, but for now you'll find the full press release after the break.

Filed under:

Comments

Source: http://feeds.engadget.com/~r/weblogsinc/engadget/~3/bsSjGRWl76M/

barefoot bandit polar bear plunge lovelace jana kramer carrie underwood melissa mccarthy

Lenovo IdeaTab Lynx review: a decent Windows 8 tablet, but not Lenovo's best

Lenovo IdeaTab Lynx review: a decent Windows 8 tablet, but not Lenovo's best

If Windows 8 tablets with Intel's Clover Trail silicon under the hood were once a curiosity, well, they're certainly not novelties anymore. We've seen lower-powered hybrids from virtually every PC maker, providing a cheaper counterpoint to Core i5 and i7 systems, but still offering useful accessories like keyboard docks. In addition to one of our favorite Atom-powered slates, the ThinkPad Tablet 2, Lenovo is shilling the IdeaTab Lynx (also known as the IdeaTab K3011) for $549 and up. So how does this system stack up? Click through to find out.

Filed under: ,

Comments

Source: http://feeds.engadget.com/~r/weblogsinc/engadget/~3/cND6FgbAdyc/

the replacements how to hard boil eggs new nfl uniforms derbyshire the matrix oceans 11 ferris state hockey

Sunday, April 7, 2013

'She was doing what she loved': Young diplomat among 6 Americans killed in Afghanistan

Diplomat Anne Smedinghoff was among the six Americans killed in two separate attacks in Afghanistan on Saturday -- the deadliest day for Americans in that country since August. NBC's Ron Mott reports.

By Marian Smith, NBC News

Family, friends and State Department colleagues on Sunday were mourning the first death of an American diplomat on duty since Ambassador Chris Stevens was killed in the attack on the U.S. Consulate in Benghazi, Libya on Sept. 11 last year.

Anne Smedinghoff, 25, was one of five Americans killed in a car bomb attack on Saturday in Zabul Province, Afghanistan, Secretary of State John Kerry said Sunday. Three of the dead were U.S. service members and the fifth a civilian employee of the Defense Department, Kerry said.

They had not been named as of Sunday morning.

Several Afghans and four other State Department employees were injured, one critically.

A sixth American civilian working with the U.S. government was killed in a separate attack in eastern Afghanistan on Saturday, ISAF said in a statement.

"It's a grim reminder to all of us, though we didn't need any reminders, of how important and also how risky carrying the future is with people who want to resist," Kerry told State Department employees on Sunday during a visit in Istanbul, Turkey.

Smedinghoff and the other Americans were traveling in a convoy to southern Afghanistan to deliver textbooks to children in Qalat, Kerry said.?

Buzkashi Boys is an intense, gritty film made in Afghanistan about two street children. After numerous international awards, the movie is now eligible to be nominated for an Academy Award. ITN's Emma Murphy reports.

He met the Illinois-native several weeks ago when she worked as his control officer during his recent trip to Afghanistan.?He described her as "vivacious, smart, capable."

"There are no words for anyone to describe the extraordinary harsh contradiction for a young 25-year-old woman, with all of her future ahead of her, believing in the possibilities of diplomacy to improve people's lives, making a difference, having an impact" to be killed, Kerry said.

He described Smedinghoff as "a selfless, idealistic woman who woke up yesterday morning and set out to bring textbooks to school children, to bring them knowledge."

Smedinghoff previously served in Venezuela.

In an email to the Washington Post, Smedinghoff's parents said their daughter "was always looking for opportunities to reach out and help to make a difference in the lives of those living in a country ravaged by war."

The two Afghan teens who starred in the short critically acclaimed film 'Buzkashi Boys' landed at LAX this week to attend the Oscars. It was a far cry from their home country, where one of the boys ? Fawad ? sold maps on the streets to help support his family. NBC's Kristen Dahlgren reports.

They added: "We are consoled knowing that she was doing what she loved, and that she was serving her country by helping to make a positive difference in the world."

Smedinghoff recently helped NBC News coordinate a report on "Buzkashi Boys," the short film nominated for an Oscar starring an Afghan boy who was discovered on the streets of Kabul.

Local Afghan producer Khyber Shinwari described her as "a lovely lady, charming ? smiling on her face."

"She was very open and so helpful. So kind," he said. "She was here to help Afghans."

The Taliban claimed responsibility for the Zabul attack in a text message Saturday. The assault came just three days after 54 people were killed in another Taliban attack on a courtroom in the western Farah province of Afghanistan.

The United Nations has said civilians are increasingly being targeted this year.

On his first day in office, Kerry said the safety of State Department employees was a top priority, in the wake of the attack that killed Ambassador Stevens and three other Americans in Benghazi. No one has been convicted as of yet.

NBC News' Jamieson Lesko, Kiko Itsaka and Catherine Chomiak, and The Associated Press and Reuters contributed to this report.

Related:

'We have to go': Afghans ready to flee country as foreign troops withdraw

54 killed, 90 wounded in attack on Afghan compound

Tears of joy: The moment an Afghan teen learned of Oscar nomination

Source: http://feeds.nbcnews.com/c/35002/f/653387/s/2a6dc143/l/0Lworldnews0Bnbcnews0N0C0Inews0C20A130C0A40C0A70C17640A3110Eshe0Ewas0Edoing0Ewhat0Eshe0Eloved0Eyoung0Ediplomat0Eamong0E60Eamericans0Ekilled0Ein0Eafghanistan0Dlite/story01.htm

miami dolphins buffalo bills pittsburgh steelers seattle seahawks ryan tannehill cispa space shuttle new york

EU: No deal reached at nuclear talks with Iran

Secretary of Iran?s Supreme National Security Council, Saeed Jalili grimaces while listening to a question during his news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

Secretary of Iran?s Supreme National Security Council, Saeed Jalili grimaces while listening to a question during his news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

EU foreign policy chief Catherine Ashton leaves her news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

Secretary of Iran?s Supreme National Security Council, Saeed Jalili listens to a question during his news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

Secretary of Iran?s Supreme National Security Council, Saeed Jalili prepars to listen to a question during his news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

EU foreign policy chief Catherine Ashton answers a question during her news conference after the high-level talks between world powers and Iranian officials in Almaty, Kazakhstan, Saturday, April 6, 2013. Iran and six world powers failed to reach agreement Saturday on a common approach to reducing fears that Tehran might misuse its nuclear technology to make weapons, with the EU?s foreign policy chief declaring that the to sides ??remain far apart on substance.?? (AP Photo/Pavel Mikheyev)

(AP) ? Iran and six world powers failed to reach agreement Saturday on how to reduce fears that Tehran might use its nuclear technology to make weapons, extending years of inconclusive talks and adding to concerns the diplomatic window on reaching a deal with Tehran may soon close.

Expectations the negotiations were making progress rose as an afternoon session continued into the evening. But comments by the two sides after they ended made clear that they fell far short of making enough headway to qualify the meeting as a success.

"What matters in the end is substance, and ... we are still a considerable distance apart," Catherine Ashton, the European Union's head of foreign policy, told reporters at the end of the two-day talks.

Ashton, the convener of the meeting, said negotiators would now consult with their capitals. She made no mention of plans for new talks ? another sign that the gap dividing the two sides remains substantial. She said she would talk with chief Iranian negotiator Saeed Jalili by telephone over further steps.

Jalili spoke of "some distance between the positions of the two sides." He suggested Iran was ready to discuss meeting a key demand of the other side ? cutting back its highest-grade uranium enrichment production and stockpile ? but only if the six reciprocated with rewards far greater than they are now willing to give.

While no breakthrough had been expected, the lack of forward movement in international negotiations that started a decade ago was certain to increase concerns that diplomacy was ineffective as a tool to stop Iran from moving toward nuclear-weapon making capacity.

Israel is most worried. The Jewish state says Iran is only a few months away from the threshold of having material to turn into a bomb and has vowed to use all means to prevent it from reaching that point. The U.S. has not said what its "red line" is, but has said it will not tolerate an Iran armed with nuclear weapons.

"The Iranians are using the round of talks to pave the way toward a nuclear bomb," said Yuval Steinitz, the Israeli minister for intelligence and strategic affairs, in a text message to reporters. "Israel has already warned that the Iranians are taking advantage of the rounds of talks in order to buy time to advance in uranium enrichment, step by step, toward a nuclear weapon."

Urging the international community to set a "short, clear and final timetable" for further talks, he said "the time has come for the world to show a more aggressive position and make it abundantly clear to the Iranians that their game of negotiations is coming to an end."

Any strike on Iran could provoke fierce retaliation directly from Iran and through its Middle East proxies in Syria, Lebanon and Palestine, raising the specter of a larger Middle East conflict and adding to the urgency of keeping both sides at the negotiating table.

At the talks in the Kazakh city of Almaty, the U.S., Russia, China, Britain, France and Germany were asking Tehran to greatly limit its production and stockpiling of uranium enriched to 20 percent, which is just a technical step away from weapons-grade uranium. That would keep Iran's supply below the amount needed for further processing into a weapon.

But the group views that only as a first step in a process. Iran is operating more than 10,000 centrifuges. While most are enriching below 20 percent, this material, too could be turned into weapons-grade uranium, although with greater effort than is the case for the 20-percent stockpile.

Tehran also is only a few years away from completing a reactor that will produce plutonium, another pathway to nuclear arms.

The U.N. Security Council has demanded a stop to both that effort and all enrichment in a series of resolutions since 2006. Iran denies any interest in atomic arms, insists its enrichment program serves only peaceful needs, says it has a right to enrich under the Nuclear Nonproliferation Treaty and describes U.N. Security Council demands as illegal.

The lack of progress at Almaty was a clear indication that Tehran wants greater rewards for any concessions that the six are ready to give. Among other incentives, they have offered to lift sanctions on Iran's gold transactions and petrochemical trade. But Iran demands much more substantial sanctions relief, including an end to international penalties crippling its oil trade and financial transactions

A senior U.S. official cited Iranian officials who described the six-power offer of limited sanctions relief in exchange for meeting their demands on 20-percent uranium as a "turning point" when the two sides met last month. The official said the U.S. administration was "disappointed that this rhetoric did not carry over into our negotiations."

The official demanded anonymity as a condition for participation in a post-meeting briefing for reporters.

Jalili in turn urged the six powers to demonstrate their "willingness and sincerity" by taking appropriate confidence-building steps in the future" ? shorthand for Iran's demand to lift major sanctions and offer other concessions.

At the same time, he suggested some potential give on the Iranian side, suggesting discussion on some curbs of 20-percent enrichment "can be continued in the talks" if the six "move away from hostile treatment ... of the Iranian people."

With Iran previously describing the crushing sanctions on its oil exports and financial transactions as hostile acts, his comments suggested that Iran would consider compromise only if those penalties were lifted. That is far more than the relief being offered, with the six prepared to remove sanctions only on Tehran's gold transactions and petrochemical exports.

In demanding recognition of its right to enrich, Iran may hope to exploit some differences among the six, with Russia in recent months pushing for concessions on that point as a way to break negotiating deadlock.

Russian Deputy Foreign Minister Sergei Ryabkov, who led his country's delegation at Almaty, said after the talks that Moscow "considers that it's necessary to recognize all rights of Iran, including enrichment." In exchange, he said Iran must accept more international monitoring of its nuclear program.

A British Foreign Office statement said "a wide gap remains between the parties. Iran's current position falls far short of what is needed to achieve a diplomatic breakthrough."

Indirectly warning of further sanctions, the statement urged Tehran to "consider carefully whether it wants to continue on its current course, and face increasing pressure and isolation from the international community, or to enter into meaningful negotiations."

But Ryabkov described the meeting as "undoubtedly a step forward." Those remarks, and his comments on enrichment, both to Russian news agencies, suggested differences exist among the six, despite assertions by negotiators from Western nations of total unity at the negotiations.

___

Associated Press writers Mansur Mirovalev in Almaty, Daniel Estrin in Jerusalem, James Heinz in Moscow and Cassandra Vinograd in London contributed to this report.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/cae69a7523db45408eeb2b3a98c0c9c5/Article_2013-04-06-Iran-Nuclear/id-eca2d81ea7ea465587551db750fefc02

Big Bird Adam Greenberg Fall Leaves Jim Lehrer 666 Park Avenue Kara Alongi Sahara Davenport

Friday, April 5, 2013

Penn Medicine's new center for personalized diagnostics unlocks cancer's secrets

Apr. 5, 2013 ? Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above. The foreboding shadows and shapes that appear on CT scans and MRIs -- and even in the field that doctors see when they zoom in to look at cancer cells under a high-powered microscope -- are just the tip of the iceberg.

Penn Medicine's new Center for Personalized Diagnostics, a joint initiative of the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and the Abramson Cancer Center, is diving deeper into each patient's tumor with next generation DNA sequencing. These specialized tests can refine patient diagnoses with greater precision than standard imaging tests and blood work, all with an aim to broaden treatment options and improve their efficacy.

"We're using the most advanced diagnostic methods to unlock cancer's secrets," says David B. Roth, MD, PhD, chairman of the department of Pathology and Laboratory Medicine. "A tumor's genomic profile is the most critical piece of information for an oncologist to have when they're deciding what therapy to recommend. The results of tests in the Center for Personalized Diagnostics reveal a genetic blueprint of each patient's tumor that is as discrete and singular as a fingerprint."

The Center for Personalized Diagnostics unites top experts in genomic analysis, bioinformatics, and cancer genetics -- who use the most sensitive data analysis tools available to identify the rarest of mutations -- with oncologists who treat patients and design clinical trials to test new therapies. Together, their efforts will provide cancer patients with cutting-edge diagnostic and therapeutic options.

The first group of patients who are undergoing testing through the CPD includes those with blood cancers and solid tumors of the brain, melanoma, and lung. Throughout 2013, the tests will be expanded for a wider range of cancer patients. Results are available within two weeks -- twice as fast as most commercially available testing panels. All new and relapsed Abramson Cancer Center patients will receive this testing -- conducted via simple blood tests and/or biopsy of tumor tissue or bone marrow -- as part of their evaluation and diagnostic process. Interpretation of results is communicated one-on-one to patients and their caregivers by physicians and genetic counselors.

In contrast to the CPD's offerings, individual genetic tests -- which now proliferate in the marketplace, even for healthy people who may be interested in going on a spelunking expedition through their DNA -- are time consuming and expensive to conduct, and they often yield information which is not clinically actionable. When these tests are offered for cancer patients, patients are often left with only a veritable alphabet soup detailing genetic information, with few plans for how to use those findings to conquer their cancer.

Since the CPD began operating in early 2013, however, tests in 80 percent of patients revealed genetic mutations that may be used to alter their treatment course or clarify their prognosis. The results are playing a role in:

  • Matching patients with existing therapies designed to target mutations previously associated only with different cancers. For instance, some lung cancer patients exhibit mutations of the BRAF gene, which is targeted by drug Vemurafenib, initially developed and approved for melanoma. Testing in the Center for Personalized Diagnostics is helping clinicians make new connections that will expand the indications for existing drugs.
  • Helping physicians determine which treatments a patient will respond to, or how well they will tolerate a particular treatment. Patients with the blood cancer acute myelogenous leukemia who express a mutation known as DNMT3A, for instance, are known to respond to higher doses of the drug daunorubicin. Learning this type of information prior to beginning treatment can help oncologists select and dose drugs in a way that will reduce side effects and boost patients' quality of life during treatment -- and increase their chance of completing their prescribed regimen.
  • Identifying patients who are likely to have a poor prognosis if treated with first-line therapies, which allows clinicians to set up a cascade of alternative therapies or, in the case of some blood cancer patients, expedite the search for a matching bone marrow donor.
  • Detecting resistance mutations that could slow or halt patients' response to targeted drugs, which allows for custom-designed combination therapies to attack tumors through multiple pathways.

The Center's research agenda operates in parallel with its clinical care mission. Each patient's test results will add to an enormous repository of genomic mutation profiles that, combined with the ability to follow patients over time, will help clinical researchers identify new markers and mutation profiles to better predict the course of an individual patient's treatment response and suggest new targets for therapy. As new mutations are detected and novel treatment options are identified, the gene testing panels will be modified and expanded, creating an evolving, real-time mutation profiling option.

"We see 11,500 newly diagnosed patients each year in the Abramson Cancer, and hundreds of others who seek our help when their cancers have not responded, or have returned, after receiving standard therapies elsewhere," said Chi Van Dang, MD, PhD, director of the Abramson Cancer Center. "A key part of our mission is to provide each of these patients these tests as soon as possible, so that we can quickly tailor a treatment regimen that provides them the greatest chance of a cure."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Perelman School of Medicine at the University of Pennsylvania.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/genes/~3/m4ztSlvAFzs/130405104723.htm

agoraphobia andrew lloyd webber obscura grok cirque du freak paul pierce pope joan

He was a splendid military gambler, dominating the problems of...

He was a splendid military gambler, dominating the problems of supply and scornful of opposition?? His ardor and daring inflicted grievous disasters upon us, but he deserves the salute which I made him ? and not without some reproaches from the public ? in the House of Commons in January 1942, when I said of him, ?We have a very daring and skillful opponent against us, and, may I say across the havoc of war, a great general.?

He also deserves our respect because, although a loyal German soldier, he came to hate Hitler and all his works, and took part in the conspiracy to rescue Germany by displacing the maniac and tyrant.?For this, he paid the forfeit of his life. In the sombre wars of modern democracy, chivalry finds no place ? Still, I do not regret or retract the tribute I paid to Rommel, unfashionable though it was judged.

Source: http://scuttlebuttstuch.tumblr.com/post/47214608140

anna paquin warren buffett 2012 nfl schedule dishonored april 18 delonte west vanessa williams